Speaking with...

File 20170522 12231 1aqktuj.jpg?ixlib=rb 1.1

Speaking with: Dr Mark Blaskovich on antibiotic-resistant bacteria and the threat of superbugs

Antibiotics Staphylex, used to treat the infection Golden Staph. TONY PHILLIPS/ AAP

Speaking with: Dr Mark Blaskovich on antibiotic-resistant bacteria and the threat of superbugs

Speaking with: Dr Mark Blaskovich on antibiotic-resistant bacteria and the threat of superbugs. The Conversation, CC BY-ND45.2 MB (download)

Since the discovery of antibiotics in the mid-20th century, millions of lives have been saved from bacterial infections. But the over-prescription of these drugs has led to some types of bacteria becoming resistant to treatment.

It’s estimated at least two million people are infected with antibiotic-resistant bacteria in the United States each year. These “superbugs” can spread rapidly and stopping them is increasingly challenging as new antibiotics need to be developed to treat them.

William Isdale spoke to Dr Mark Blaskovich about the the overuse of antibiotics and the risks superbugs pose to communities.


Subscribe to The Conversation’s Speaking With podcasts on iTunes, or follow on Tunein Radio.

Additional Audio

Music